BR0010598A - Azoles substituìdos - Google Patents

Azoles substituìdos

Info

Publication number: BR0010598A
Authority: BR; Brazil
Prior art keywords: azoles; replaced; tnf; meanings; inhibitors
Prior art date: 1999-04-14

Application number

BR0010598-8A

Other languages

English (en)

Portuguese (pt)

Inventor

Laszlo Revesz

Achim Schlapbach

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2000-04-12

Publication date

2002-02-05

1999-04-14 Priority claimed from GBGB9908532.6A external-priority patent/GB9908532D0/en

1999-04-14 Priority claimed from GBGB9908531.8A external-priority patent/GB9908531D0/en

2000-04-12 Application filed by Novartis Ag filed Critical Novartis Ag

2002-02-05 Publication of BR0010598A publication Critical patent/BR0010598A/pt

Links

150000003851 azoles Chemical class 0.000 title abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
108010002352 Interleukin-1 Proteins 0.000 abstract 1
208000001132 Osteoporosis Diseases 0.000 abstract 1
230000004097 bone metabolism Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR0010598-8A 1999-04-14 2000-04-12 Azoles substituìdos BR0010598A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9908532.6A GB9908532D0 (en)	1999-04-14	1999-04-14	Organic compounds
GBGB9908531.8A GB9908531D0 (en)	1999-04-14	1999-04-14	Organic compounds
PCT/EP2000/003290 WO2000063204A2 (fr)	1999-04-14	2000-04-12	Azoles substitues

Publications (1)

Publication Number	Publication Date
BR0010598A true BR0010598A (pt)	2002-02-05

Family

ID=26315413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0010598-8A BR0010598A (pt)	1999-04-14	2000-04-12	Azoles substituìdos

Country Status (25)

Country	Link
US (1)	US6579874B2 (fr)
EP (1)	EP1224180B1 (fr)
JP (1)	JP2003503311A (fr)
KR (1)	KR20010108504A (fr)
CN (1)	CN1378544A (fr)
AR (1)	AR023465A1 (fr)
AT (1)	ATE244236T1 (fr)
AU (1)	AU4295300A (fr)
BR (1)	BR0010598A (fr)
CA (1)	CA2370417A1 (fr)
CO (1)	CO5170501A1 (fr)
CZ (1)	CZ20013696A3 (fr)
DE (1)	DE60003709T2 (fr)
DK (1)	DK1224180T3 (fr)
ES (1)	ES2202114T3 (fr)
HU (1)	HUP0302747A2 (fr)
IL (1)	IL145836A0 (fr)
MX (1)	MXPA01010434A (fr)
NO (1)	NO20014987L (fr)
PE (1)	PE20010031A1 (fr)
PL (1)	PL364789A1 (fr)
PT (1)	PT1224180E (fr)
SK (1)	SK14562001A3 (fr)
TR (1)	TR200102967T2 (fr)
WO (1)	WO2000063204A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA02003436A (es)	1999-10-07	2002-08-20	Amgen Inc	Inhibidores de triazina cinasa.
AU7922900A (en) *	1999-10-27	2001-05-08	Novartis Ag	Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
AU3704101A (en) *	2000-02-17	2001-08-27	Amgen Inc	Kinase inhibitors
BR0116452A (pt)	2000-12-21	2003-09-30	Glaxo Group Ltd	Composto, composição farmacêutica, uso de um composto
WO2002051442A1 (fr) *	2000-12-26	2002-07-04	Takeda Chemical Industries, Ltd.	Co-prescriptions
US7199124B2 (en)	2001-02-02	2007-04-03	Takeda Pharmaceutical Company Limited	JNK inhibitor
AP2002002460A0 (en)	2001-03-09	2002-06-30	Pfizer Prod Inc	Novel benzimidazole anti-inflammatory compounds.
HUP0303415A2 (hu)	2001-03-09	2004-01-28	Pfizer Products Inc.	Triazolopiridinek, mint gyulladásgátló anyagok és ezeket tartalmazó gyógyszerkészítmények
DE60205974T2 (de)	2001-04-04	2006-06-29	Pfizer Products Inc., Groton	Neue Benzotriazole mit entzündungshemmender Wirkung
EP1402900A1 (fr) *	2001-06-11	2004-03-31	Takeda Chemical Industries, Ltd.	Compositions medicinales
TWI231757B (en) *	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
KR100903760B1 (ko)	2001-09-21	2009-06-19	솔베이 파마슈티칼스 비. 브이	Ｃｂ1-길항 작용을 가지는 신규한4,5-디하이드로-1ｈ-피라졸 유도체
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
WO2003053922A2 (fr) *	2001-12-19	2003-07-03	Merck & Co., Inc.	Imidazoles substitues par heteroaryle modulateurs du recepteur metabotropique du glutamate de type 5
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
ES2278170T3 (es)	2002-07-09	2007-08-01	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
US7074809B2 (en)	2002-08-09	2006-07-11	Astrazeneca Ab	Compounds
TW200424183A (en) *	2002-08-09	2004-11-16	Nps Pharma Inc	New compounds
WO2004014881A2 (fr)	2002-08-09	2004-02-19	Astra Zeneca Ab	Nouveaux composes
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
US7037923B2 (en)	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
WO2004020438A2 (fr) *	2002-08-30	2004-03-11	Pfizer Products Inc.	Nouveaux procedes et produits intermediaires pour preparer des triazolo-pyridines
US7005523B2 (en)	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
US6949652B2 (en)	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
PA8579601A1 (es)	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
AU2003300076C1 (en)	2002-12-30	2010-03-04	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
US7622471B2 (en)	2003-02-07	2009-11-24	Daiichi Pharmaceutical Co., Ltd.	Pyrazole derivatives having a pyridazine and pyridine functionality
EP1601672B1 (fr)	2003-02-14	2006-07-26	Pfizer Products Inc.	Triazolo-pyridines utilisees comme composes anti-inflammatoires
TWI326282B (en) *	2004-04-28	2010-06-21	Mitsubishi Tanabe Pharma Corp	Heterocyclic compound
US7858800B2 (en)	2004-06-30	2010-12-28	Banyu Pharmaceutical Co., Ltd.	Biaryl derivatives
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP3143926B1 (fr) *	2006-02-08	2020-07-01	The General Hospital Corporation	Procédés, agencements et systèmes pour obtenir des informations associées à un prélèvement anatomique utilisant la microscopie optique
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
NZ580660A (en)	2007-04-30	2012-02-24	Abbott Lab	Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
EP1992344A1 (fr)	2007-05-18	2008-11-19	Institut Curie	P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
US9029411B2 (en)	2008-01-25	2015-05-12	Millennium Pharmaceuticals, Inc.	Thiophenes and uses thereof
EP2108641A1 (fr)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	Nouveaux dérivés substitués de spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one et leur utilisation comme ihibiteurs de p38 mitogen-activated kinase
EP2113503A1 (fr)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	Nouveaux dérivés d'indolin-2-one substitués et leur utilisation comme inhibiteurs de p38 mitogen-activated kinase
WO2010090716A1 (fr)	2009-01-30	2010-08-12	Millennium Pharmaceuticals, Inc.	Hétéroaryles et applications associées
US9090601B2 (en)	2009-01-30	2015-07-28	Millennium Pharmaceuticals, Inc.	Thiazole derivatives
US8796314B2 (en)	2009-01-30	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
MX2011012343A (es) *	2009-05-19	2011-12-14	Dow Agrosciences Llc	Compuestos y metodos para controlar hongos.
EP2322176A1 (fr)	2009-11-11	2011-05-18	Almirall, S.A.	Nouveaux dérivés de 7-phényl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
WO2012021611A1 (fr)	2010-08-11	2012-02-16	Millennium Pharmaceuticals, Inc.	Hétéroaryles et utilisations de ceux-ci
TW201217365A (en)	2010-08-11	2012-05-01	Millennium Pharm Inc	Heteroaryls and uses thereof
US8859768B2 (en)	2010-08-11	2014-10-14	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
TW201307309A (zh)	2010-10-13	2013-02-16	Millennium Pharm Inc	雜芳基化合物及其用途
AR086113A1 (es)	2011-04-30	2013-11-20	Abbott Lab	Isoxazolinas como agentes terapeuticos
US20190060286A1 (en)	2016-02-29	2019-02-28	University Of Florida Research Foundation, Incorpo	Chemotherapeutic Methods
WO2018159650A1 (fr) *	2017-02-28	2018-09-07	東レ株式会社	Dérivé de guanidine et son utilisation médicinale
US12441707B2 (en)	2019-12-30	2025-10-14	Tyra Biosciences, Inc.	Indazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0727998B1 (fr) *	1993-11-08	2004-01-21	Smithkline Beecham Corporation	Oxazoles pour le traitement de maladies induites par la cytokine
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
IL118544A (en) *	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
JP3294616B2 (ja) *	1995-08-10	2002-06-24	メルクエンドカンパニーインコーポレーテッド	２−置換アリールピロール、このような化合物を含む組成物及び使用方法
US6492516B1 (en) *	1999-05-14	2002-12-10	Merck & Co., Inc.	Compounds having cytokine inhibitory activity

2000
- 2000-04-11 CO CO00026470A patent/CO5170501A1/es not_active Application Discontinuation
- 2000-04-12 DK DK00922630T patent/DK1224180T3/da active
- 2000-04-12 PL PL00364789A patent/PL364789A1/xx not_active Application Discontinuation
- 2000-04-12 KR KR1020017013086A patent/KR20010108504A/ko not_active Withdrawn
- 2000-04-12 CZ CZ20013696A patent/CZ20013696A3/cs unknown
- 2000-04-12 AU AU42953/00A patent/AU4295300A/en not_active Abandoned
- 2000-04-12 PT PT00922630T patent/PT1224180E/pt unknown
- 2000-04-12 PE PE2000000337A patent/PE20010031A1/es not_active Application Discontinuation
- 2000-04-12 MX MXPA01010434A patent/MXPA01010434A/es unknown
- 2000-04-12 EP EP00922630A patent/EP1224180B1/fr not_active Expired - Lifetime
- 2000-04-12 JP JP2000612294A patent/JP2003503311A/ja active Pending
- 2000-04-12 AT AT00922630T patent/ATE244236T1/de not_active IP Right Cessation
- 2000-04-12 BR BR0010598-8A patent/BR0010598A/pt not_active IP Right Cessation
- 2000-04-12 TR TR2001/02967T patent/TR200102967T2/xx unknown
- 2000-04-12 WO PCT/EP2000/003290 patent/WO2000063204A2/fr not_active Ceased
- 2000-04-12 DE DE60003709T patent/DE60003709T2/de not_active Expired - Fee Related
- 2000-04-12 IL IL14583600A patent/IL145836A0/xx unknown
- 2000-04-12 HU HU0302747A patent/HUP0302747A2/hu unknown
- 2000-04-12 ES ES00922630T patent/ES2202114T3/es not_active Expired - Lifetime
- 2000-04-12 CA CA002370417A patent/CA2370417A1/fr not_active Abandoned
- 2000-04-12 CN CN00807552A patent/CN1378544A/zh active Pending
- 2000-04-12 SK SK1456-2001A patent/SK14562001A3/sk unknown
- 2000-04-12 AR ARP000101686A patent/AR023465A1/es unknown
2001
- 2001-10-12 US US09/975,913 patent/US6579874B2/en not_active Expired - Fee Related
- 2001-10-12 NO NO20014987A patent/NO20014987L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ20013696A3 (cs)	2002-02-13
WO2000063204A2 (fr)	2000-10-26
PT1224180E (pt)	2003-11-28
US6579874B2 (en)	2003-06-17
JP2003503311A (ja)	2003-01-28
AR023465A1 (es)	2002-09-04
NO20014987L (no)	2001-12-14
PE20010031A1 (es)	2001-02-23
US20020049220A1 (en)	2002-04-25
IL145836A0 (en)	2002-07-25
AU4295300A (en)	2000-11-02
DE60003709T2 (de)	2004-12-23
HUP0302747A2 (hu)	2003-12-29
MXPA01010434A (es)	2002-03-27
NO20014987D0 (no)	2001-10-12
DE60003709D1 (de)	2003-08-07
EP1224180B1 (fr)	2003-07-02
ES2202114T3 (es)	2004-04-01
SK14562001A3 (sk)	2002-03-05
DK1224180T3 (da)	2003-10-20
WO2000063204A3 (fr)	2002-05-23
ATE244236T1 (de)	2003-07-15
TR200102967T2 (tr)	2002-01-21
PL364789A1 (en)	2004-12-13
CO5170501A1 (es)	2002-06-27
EP1224180A2 (fr)	2002-07-24
KR20010108504A (ko)	2001-12-07
CA2370417A1 (fr)	2000-10-26
CN1378544A (zh)	2002-11-06

Legal Events

Date	Code	Title	Description
2007-12-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES.
2011-12-13	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.

Publication	Publication Date	Title
BR0010598A (pt)	2002-02-05	Azoles substituìdos
ATE349435T1 (de)	2007-01-15	Dpiv-inhibitoren auf glutaminbasis
DOP2002000336A (es)	2003-01-31	Inhibidores de benzotiadiazina de metaloproteinasas de la matriz
TR200102131T2 (tr)	2001-12-21	Matrisk metaloproteinaz inhitörleri olarak 2,3,4,5-tetrahidro-1H[1,4] benzodiyazepin-3- hidroksamik asitler.
GB0121033D0 (en)	2001-10-24	Organic compounds
AU2003209118A1 (en)	2003-09-04	Aryl ureas as kinase inhibitors
JO2534B1 (en)	2010-09-05	Pyrimidines carrying alternatives of sulfoximine as CDK and / or VEGF inhibitors and their production and use as pharmaceutical agents
EA200300248A1 (ru)	2003-08-28	Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
BR9908332A (pt)	2000-11-07	Derivados de n-[carbonil(anel di ou triaza diinsaturado de cinco membros substituìdo)] derivados de guanidina para tratamento de esquemia
BR0306988A (pt)	2004-11-23	Piridazinonas substituìdas como inibidores de p38
DE60135029D1 (de)	2008-09-04	Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis
DE60313624D1 (de)	2007-06-14	Derivate von heteroarylnitrilverbindungen
BR0016878A (pt)	2002-10-08	Inibidores tricìclicos de cinases protéicas
DE60037836D1 (de)	2008-03-06	ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
ES2171723T3 (es)	2002-09-16	3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
DK1045690T3 (da)	2003-08-04	Benzensulfonamidinhibitorer af PDE-IV og deres terapeutiske anvendelse
ATE266623T1 (de)	2004-05-15	Caspase inhibitoren und deren verwendung
ATE232873T1 (de)	2003-03-15	Phosphonsaürederivate als ptp-1b-inhibitoren
NO20056161L (no)	2005-12-23	Formuleringer for behandling av artrittilstander
BR9916324A (pt)	2001-10-02	4,5-pirazinoxindóis como inibidores de proteìna quinase
MXPA05007607A (es)	2005-09-30	Inhibidores amida y ester de la metaloproteinasa de matriz.
ATE302002T1 (de)	2005-09-15	Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE290857T1 (de)	2005-04-15	Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DK1109818T3 (da)	2003-03-03	Phosphoepoxider, fremgangsmåder til deres fremstilling og deres anvendelser
MY128242A (en)	2007-01-31	Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf